News and Announcements
Universal Biosenors Acquires Hemostasis Reference Laboratory
- Published December 19, 2016 12:57PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
19th December 2016 – ASX Announcement
Universal Biosensors Inc (ASX: UBI) has announced that its wholly-owned Canadian operating subsidiary has signed an agreement with LifeLabs LP (LifeLabs) to acquire the assets of LifeLabs’ Hemostasis Reference Laboratory business (HRL) in preparation for future increased production requirements of Siemens’ Xprecia Stride™ test strips.
The HRL business has provided high-quality coagulation testing and calibration services to international customers for more than 20 years, including 5 years of services for UBI. HRL has one of the most diverse offerings of specialised coagulation services in the world.
To view the full announcement please click on the button below.
Company Updates
Navigating the Market Inflection Point: Exclusive Investor & Founder Meetups Across Australia
The market is at a genuine inflection point in mid-2025, with conflicting signals from AI breakthroughs and geopolitical shifts. This blog announces exclusive, intimate investor and founder meetups across Australia, designed to cut through the noise, reveal unfiltered truths about the H2 2025 outlook, and map the “smart money migration” to position participants for strategic advantage.
Bridging the Gap: Why Australian Capital is Crucial for India’s Trillion-Dollar Growth Story
Australia’s substantial savings pool is meeting India’s explosive growth. Learn how Creek Partners is building the crucial bridge for investors seeking to tap into India’s projected $7 trillion economy and its vibrant venture capital ecosystem.
Beyond the Hype: Strategic Digital Asset Investing for a New Financial Era
The financial world is undergoing a profound transformation driven by Digital Assets. Learn why hundreds of billions are pouring into new digital infrastructure, with stablecoins now outperforming Mastercard/Visa in transaction volume. This article guides investors beyond the hype to strategic digital asset investing, exploring yield, DePIN, DeFi, and AI+Blockchain for the new financial era. Discover more at Venture & Capital SYDNEY 2025.
Backed By Leading Investment Groups and Family Offices
